1 / 17

Management Team

Management Team. Dr Stephen Edwards: Commercial and Managing Director PhD Industrial Biotechnology, Knowledge Transfer Manager. Professor Mathew Brown: Research and Development Director Professor of Cell Biology & Applied Virology. Dr Amos Iorliam: Operations Director

pbradshaw
Télécharger la présentation

Management Team

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Management Team Dr Stephen Edwards: Commercial and Managing Director PhD Industrial Biotechnology, Knowledge Transfer Manager Professor Mathew Brown: Research and Development Director Professor of Cell Biology & Applied Virology Dr Amos Iorliam: Operations Director MBA Harvard University, LLP Ruth Kennedy-Walker: Finance Director MBA, FCA, Chartered accountant: PWC

  2. Cost of Corrosion in the Oil Industry £12.1 Billion COST OF PIPELINE CORROSION £3.6 Billion COST OF MIC

  3. Microbial Influenced Corrosion

  4. Microbial Influenced Corrosion Metabolites

  5. Cost of MIC in the Oil Industry £12.1 Billion COST OF PIPELINE CORROSION £3.6 Billion COST OF MIC £1.9 Billion

  6. MIC Mitigation/Maintenance • Dewatering • Physical Cleaning (Pigging) • Flushing/Addition of Biocides • Introduction of Chemical Inhibitors • Internal pipeline coatings

  7. MIC Phage Therapy

  8. Phage Therapy Vs. Biocides/Inhibitors • Lab Scale Results: • Reduced Biofilm Formation by up to 20% • Reduced MIC Causing Bacteria by 60% • Reduced Corrosion by up to 25% Biocide Addition Phage Addition

  9. Market Opportunity £1.9 Billion p.a £475 Million p.a

  10. Where We Have Come From? Identification and Isolation of Major MIC causing Bacteria and Associated Phages 1/9/2008 - 1/9/2010 Development of Lab Scale Culture Techniques 1/9/2009 - 1/9/2011 Phage Application Experiment 1/9/2011 - 1/9/2012 IP License and Research Concordat Agreed with University 16/9/2013 - 16/9/2013 UK Priority Applications 1/11/2010 - 1/11/2010 UK IP Granted 1/5/2013 - 1/5/2013 International Patents Filed in Target Nations 1/3/2013 - 1/3/2013 2008 2009 2010 2011 2012 2013 2013 EPSRC Advanced Research Fellowship 2/12/2013 1/9/2008 Investment Pitch Formation of Spin Out Company - Phage Off 1/4/2013

  11. Business Strategy: Years 1 - 3 Scale Up of Phage Culturing Techniques 1/1/2014 - 1/7/2014 Production of Phage Culture 1/7/2014 - 1/3/2017 Scale Up of Phage Application 1/7/2014 - 1/7/2016 Identify Potential Licensees/ Building Market Presence 1/1/2016 - 1/1/2017 Continued R & D 1/1/2014 - 1/1/2017 2013 2014 2015 2016 2017 2017 Investment Pitch End of Year 1 End of Year 2 End of Year 3 2/12/2013 1/1/2015 1/1/2016 1/1/2017 Formation of Spin Out Company - Phage Off 1/4/2013

  12. Intellectual Property UK Priority Applications 1/11/2010 - 1/11/2010 UK IP Granted 1/5/2013 - 1/5/2013 International PCT Applications 1/9/2011 - 1/9/2011 International Patents Filed in Target Nations 1/3/2013 - 1/3/2013 Patents Granted in Target Nations 1/12/2014 - 1/11/2016 2010 2011 2012 2013 2014 2015 2016 2017 2017 End of Year 3 1/1/2017 End of Year 2 1/1/2016 End of Year 1 1/1/2015 Investment Pitch 2/12/2013 Formation of Spin Out Company - Phage Off 1/4/2013

  13. Expenditure: Years 1 - 3

  14. Projected Income: Years 4 - 10

  15. Growth and Future Markets Gas Oil Drinking water Wastewater

  16. Thank You

More Related